ICD-10-PCS Codes

• 1 3E0M05Z (INTRODUCTION OF ADHESION BARRIER INTO PERITONEAL CAVITY, OPEN APPROACH)

• 2 3E0M304 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 3 3E0M305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 4 3E0M30M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 5 3E0M30Y (INTRODUCTION OF HYPERTHERMIC ANTINEOPLASTIC INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 6 3E0M328 (INTRODUCTION OF OXAZOLIDINONES INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 7 3E0M329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 8 3E0M33Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 9 3E0M35Z (INTRODUCTION OF ADHESION BARRIER INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 10 3E0M36Z (INTRODUCTION OF NUTRITIONAL SUBSTANCE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 11 3E0M37Z (INTRODUCTION OF ELECTROLYTIC AND WATER BALANCE SUBSTANCE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 12 3E0M3BZ (INTRODUCTION OF ANESTHETIC AGENT INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 13 3E0M3GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 14 3E0M3HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 15 3E0M3KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 16 3E0M3NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 17 3E0M3SF (INTRODUCTION OF OTHER GAS INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 18 3E0M3TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO PERITONEAL CAVITY, PERCUTANEOUS APPROACH)

• 19 3E0M45Z (INTRODUCTION OF ADHESION BARRIER INTO PERITONEAL CAVITY, PERCUTANEOUS ENDOSCOPIC APPROACH)

• 20 3E0M4GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PERITONEAL CAVITY, PERCUTANEOUS ENDOSCOPIC APPROACH)

• 21 3E0M704 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO PERITONEAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)

• 22 3E0M705 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PERITONEAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)

• 23 3E0M70M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PERITONEAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)

• 24 3E0M7SF (INTRODUCTION OF OTHER GAS INTO PERITONEAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)